SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.000
+0.320 (8.70%)
At close: Aug 21, 2026, 4:00 PM EDT
3.995
-0.005 (-0.13%)
After-hours: Aug 21, 2026, 7:30 PM EDT
SBC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 175.17 | 173.61 | 205.42 | 193.54 | 174.16 | |
Revenue Growth | -6.92% | -15.48% | 6.13% | 11.13% | - |
Cost of Revenue | 49.3 | 46.32 | 49.37 | 56.24 | 82.16 |
Gross Profit | 125.86 | 127.28 | 156.05 | 137.3 | 92 |
Selling, General & Admin | 60.06 | 58.86 | 57.07 | 64.33 | 70.09 |
Other Operating Expenses | 0.67 | 0.94 | 0.6 | 2.31 | 1.54 |
Operating Expenses | 60.45 | 59.8 | 70.69 | 66.64 | 71.63 |
Operating Income | 65.41 | 67.49 | 85.36 | 70.66 | 20.37 |
Interest Expense | -0.35 | -0.16 | -0.03 | -0.05 | -0.03 |
Interest & Investment Income | 0.25 | 0.2 | 0.02 | 0.09 | 0.47 |
Currency Exchange Gain (Loss) | 5.72 | 2 | 0.9 | - | - |
Other Non Operating Income (Expenses) | 3.91 | 3.68 | 1.6 | 2.65 | 3.88 |
EBT Excluding Unusual Items | 74.38 | 73.21 | 87.85 | 73.36 | 24.69 |
Impairment of Goodwill | - | - | - | - | -0.25 |
Gain (Loss) on Sale of Investments | 0.53 | 0.11 | -3.15 | 0.22 | -0.76 |
Gain (Loss) on Sale of Assets | - | - | 3.81 | - | - |
Asset Writedown | - | - | -15.06 | - | - |
Other Unusual Items | - | 8.75 | - | - | - |
Pretax Income | 74.92 | 82.07 | 73.46 | 73.58 | 23.68 |
Income Tax Expense | 25.31 | 31.02 | 26.77 | 35.02 | 18.12 |
Earnings From Continuing Operations | 49.6 | 51.05 | 46.69 | 38.56 | 5.55 |
Minority Interest in Earnings | -0.58 | -0.06 | -0.08 | 0.81 | 0.76 |
Net Income | 49.03 | 50.99 | 46.61 | 39.37 | 6.32 |
Net Income to Common | 49.03 | 50.99 | 46.61 | 39.37 | 6.32 |
Net Income Growth | 47.08% | 9.38% | 18.40% | 523.44% | - |
Shares Outstanding (Basic) | 103 | 103 | 97 | 94 | 8 |
Shares Outstanding (Diluted) | 103 | 103 | 97 | 94 | 8 |
Shares Change | 1.41% | 6.67% | 2.51% | 1084.96% | - |
EPS (Basic) | 0.48 | 0.50 | 0.48 | 0.42 | 0.79 |
EPS (Diluted) | 0.48 | 0.50 | 0.48 | 0.42 | 0.79 |
EPS Growth | 45.03% | 2.54% | 15.50% | -47.39% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 60.7 | 22.3 | 17.17 | 41.15 | -24.99 |
Free Cash Flow Per Share | 0.59 | 0.22 | 0.18 | 0.44 | -3.14 |
Gross Margin | 71.85% | 73.32% | 75.97% | 70.94% | 52.83% |
Operating Margin | 37.34% | 38.87% | 41.56% | 36.51% | 11.70% |
Profit Margin | 27.99% | 29.37% | 22.69% | 20.34% | 3.63% |
Free Cash Flow Margin | 34.65% | 12.84% | 8.36% | 21.26% | -14.35% |
EBITDA | 68.63 | 70.17 | 89.16 | 82.91 | 26.3 |
EBITDA Margin | 39.18% | 40.42% | 43.41% | 42.84% | 15.10% |
D&A For EBITDA | 3.22 | 2.68 | 3.8 | 12.25 | 5.93 |
EBIT | 65.41 | 67.49 | 85.36 | 70.66 | 20.37 |
EBIT Margin | 37.34% | 38.87% | 41.56% | 36.51% | 11.70% |
Effective Tax Rate | 33.79% | 37.80% | 36.44% | 47.59% | 76.55% |
Revenue as Reported | 175.17 | 173.61 | 205.42 | 193.54 | 174.16 |
Advertising Expenses | - | 3.12 | 2.78 | 3.37 | 6.57 |